International journal of pediatric otorhinolaryngology · 2025
Trends in pediatric bone conduction hearing device selection according to demographic and socioeconomic factors.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Schertzer Joseph S, Arya Priya, Catanzarite Ashley, Holman Erin, Brooks Kaitlyn A, Alfonso Kristan P, Govil Nandini
Аннотация
OBJECTIVES: A variety of bone conduction hearing devices (BCHD) exist for the treatment of conductive hearing loss including percutaneous, passive transcutaneous, and active transcutaneous devices. The purpose of this study was to evaluate trends in selection of pediatric BCHD according to demographic and socioeconomic factors.
METHODS: A retrospective cohort study was performed on all patients who underwent BCHD placement at a tertiary academic pediatric healthcare system between January 2019 to April 2023. Audiology discussed all BCHD options during the consultation, with families deciding the ultimate device and manufacturer. Data collected for multivariate logistic regression analysis included age, gender, primary language spoken, etiology for hearing loss, and insurance type. Significance was set at p > 0.05.
RESULTS: A total of 97 patients were included in the study representing 129 devices. Twenty-eight patients received concurrent bilateral BCHD placement at initial surgery, and four underwent contralateral BCHD placement at a later date. The majority of patients received an active transcutaneous device (Med-El Bonebridge, n = 55; Cochlear Osia, n = 33), three received a passive transcutaneous device (Sophono), and ten patients received percutaneous devices (Ponto Connect, n = 3, Cochlear Connect, n = 7). Multivariate logistic regression analysis was performed on the subset of patients who received active transcutaneous devices (Med-El Bonebridge, n = 37; Cochlear Osia, n = 21) and revealed no significant relationships between demographic and socioeconomic factors and device selection (p > 0.05).
CONCLUSION: There has been a shift towards the active transcutaneous devices at our institution, with comparable audiometric outcomes between the passive transcutaneous and percutaneous devices. Selection of a pediatric BCHD is a complex decision-making process which involves interdisciplinary discussion between the audiologist, surgeon, patient, and caregivers.
METHODS: A retrospective cohort study was performed on all patients who underwent BCHD placement at a tertiary academic pediatric healthcare system between January 2019 to April 2023. Audiology discussed all BCHD options during the consultation, with families deciding the ultimate device and manufacturer. Data collected for multivariate logistic regression analysis included age, gender, primary language spoken, etiology for hearing loss, and insurance type. Significance was set at p > 0.05.
RESULTS: A total of 97 patients were included in the study representing 129 devices. Twenty-eight patients received concurrent bilateral BCHD placement at initial surgery, and four underwent contralateral BCHD placement at a later date. The majority of patients received an active transcutaneous device (Med-El Bonebridge, n = 55; Cochlear Osia, n = 33), three received a passive transcutaneous device (Sophono), and ten patients received percutaneous devices (Ponto Connect, n = 3, Cochlear Connect, n = 7). Multivariate logistic regression analysis was performed on the subset of patients who received active transcutaneous devices (Med-El Bonebridge, n = 37; Cochlear Osia, n = 21) and revealed no significant relationships between demographic and socioeconomic factors and device selection (p > 0.05).
CONCLUSION: There has been a shift towards the active transcutaneous devices at our institution, with comparable audiometric outcomes between the passive transcutaneous and percutaneous devices. Selection of a pediatric BCHD is a complex decision-making process which involves interdisciplinary discussion between the audiologist, surgeon, patient, and caregivers.